A61K 9/0012
Galenical forms characterised by the site of application
Official title: {Galenical forms characterised by the site of application}
A61K9/0012 (Galenical forms characterised by the site of application) appears on 48,413 US grants and 86,701 published applications in this corpus.
Search patents in A61K- Granted patents
- 48,413
- Published applications
- 86,701
- Assignees
- 20,435
- Inventors
- 104,197
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 103 | 0 |
| 1977 | 90 | 0 |
| 1978 | 84 | 0 |
| 1979 | 87 | 0 |
| 1980 | 89 | 0 |
| 1981 | 105 | 0 |
| 1982 | 89 | 0 |
| 1983 | 94 | 0 |
| 1984 | 118 | 0 |
| 1985 | 96 | 0 |
| 1986 | 127 | 0 |
| 1987 | 139 | 0 |
| 1988 | 168 | 0 |
| 1989 | 262 | 0 |
| 1990 | 231 | 0 |
| 1991 | 242 | 0 |
| 1992 | 257 | 0 |
| 1993 | 260 | 0 |
| 1994 | 240 | 0 |
| 1995 | 261 | 0 |
| 1996 | 338 | 0 |
| 1997 | 451 | 0 |
| 1998 | 503 | 0 |
| 1999 | 544 | 0 |
| 2000 | 481 | 0 |
| 2001 | 581 | 242 |
| 2002 | 624 | 916 |
| 2003 | 598 | 1386 |
| 2004 | 466 | 1591 |
| 2005 | 368 | 1670 |
| 2006 | 508 | 1671 |
| 2007 | 370 | 1814 |
| 2008 | 375 | 1854 |
| 2009 | 390 | 1954 |
| 2010 | 737 | 2378 |
| 2011 | 784 | 2371 |
| 2012 | 1142 | 2523 |
| 2013 | 1491 | 2886 |
| 2014 | 1976 | 3510 |
| 2015 | 2120 | 3667 |
| 2016 | 2380 | 4850 |
| 2017 | 2748 | 5124 |
| 2018 | 2721 | 4612 |
| 2019 | 2911 | 5645 |
| 2020 | 3154 | 6212 |
| 2021 | 3307 | 6150 |
| 2022 | 3130 | 5442 |
| 2023 | 2772 | 5306 |
| 2024 | 2809 | 5008 |
| 2025 | 2730 | 4417 |
| 2026 | 1762 | 3502 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- A61K 9/0019Injectable compositions19,294
- A61K 9/0053Mouth and digestive tract, i.e. intraoral and peroral administration13,628
- A61K 9/0014Skin, i.e. galenical aspects of topical compositions9,328
- A61K 9/0048Eye5,021
- A61K 9/007Pulmonary tract4,313
- A61K 9/0043Nose2,394
- A61K 9/0034Urogenital system1,956
- A61K 9/0031Rectum, anus820
All 11 subgroupsShow fewer
Recent patents
- Polymeric microstructures and systems and methods for making same6 Oct 2026US 12,751,914 B2The Board of Trustees of the Leland Stanford Junior University
- Method and apparatus for delivering an API-containing liquid to an edible substrate6 Oct 2026US 12,751,915 B2Transport Authority, Inc.
- Powder formulations for inhalation6 Oct 2026US 12,751,916 B2Christian-Albrechts-Universität zu Kiel
- Hydrogels as oral delivery dosage forms, methods of making and using same6 Oct 2026US 12,751,917 B2VeraMorph LLC
- Ketamine formulation6 Oct 2026US 12,751,918 B2Fresenius Kabi USA, LLC
- Esketamine formulations and methods for preparation and storage8 Oct 2026US 2026/0306360 A1Janssen Pharmaceutica NV
- Hyaluronic acid hydrogels with agent to enhance resorption8 Oct 2026US 2026/0306398 A1Boston Scientific Scimed, Inc.
- A consumable gel for health ingredients8 Oct 2026US 2026/0306399 A1Gelteq Limited
- Suspension containing heterocyclidene acetamide derivative8 Oct 2026US 2026/0306401 A1Mochida Pharmaceutical Co., Ltd.
- Aqueous formulations comprising fullerene, structured water, dissolved hydrogen gas, minerals and additives8 Oct 2026US 2026/0306402 A1Best Planet Science LLC
Most cited
By later US patents
- Analyte-controlled liquid delivery device and analyte monitor2,000US 5,800,420 AElan Medical Technologies Limited · 1998
- Closed porous chambers for implanting tissue in a host1,958US 5,344,454 ABaxter International Inc. · 1994
- Analyte-controlled liquid delivery device and analyte monitor1,860US 5,807,375 AElan Medical Technologies Limited · 1998
- Surgical implant and method for controlled release of chemotherapeutic agents1,679US 5,290,271 A1994
- Drug releasing biodegradable fiber implant1,662US 6,596,296 B1Board of Regents, The University of Texas System · 2003